VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
VaxCT
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Brucella abortus 60-kDa chaperonin GroEL subunit vaccine
Vaccine Information
  • Vaccine Name: Brucella abortus 60-kDa chaperonin GroEL subunit vaccine
  • Target Pathogen: Brucella spp.
  • Target Disease: Brucellosis
  • Vaccine Ontology ID: VO_0009184
  • Type: Subunit vaccine
  • Status: Research
  • Host Species for Licensed Use: Cattle
  • Antigen: 60-kDa chaperonin GroEL
  • Preparation: Identification of immunogenic proteins from B. abortus cell envelope using proteomic techniques including 2-DE, MALDI-TOF MS, and LC-MS/MS; Western blot analyses with sera from infected bovine and human patients identified immunogenic proteins. (Connolly et al, 2006)
  • Description: Live attenuated vaccines S19 and RB51 are used to control bovine brucellosis but have safety issues for humans and pregnant cattle; this study aims to identify novel candidate proteins from B. abortus cell envelope for safer vaccine development. Immune response: Several new immunogenic proteins identified by Western blot using antisera from infected bovine and human patients, indicating potential to elicit immune response. (Connolly et al, 2006)
Host Response
References
Connolly et al, 2006: Connolly JP, Comerci D, Alefantis TG, Walz A, Quan M, Chafin R, Grewal P, Mujer CV, Ugalde RA, DelVecchio VG. Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development. Proteomics. 2006 Jul; 6(13); 3767-80. [PubMed: 16739129].